RapiDA

A powerful new tool in the
fight against Age-Related
Macular Degeneration (AMD)

Detects AMD at the earliest possible stage, when treatment to help patients lead normal, full lives is most effective.

Gardening as normal thanks to RapiDA’s early-alert screeing

Early detection of AMD is vital

If detected late of not diagnosed at all, it leads to either debilitating sight loss or blindness.

RapiDA’s early alert, smart digital screening process has been developed to correct this situation and allow treatment to be administered at the point when it can most effectively interrupt or slow down the progression of the disease.

AMD is the largest cause of sight loss or blindness in the developed. The development of rapida is a big step forward in tackling this major global health problem.

RapiDA has been developed by a University of Manchester spin-out company, Mumac. Its patented technologies, which use dark adaptation, are affordable, easy to operate, have exceptional sensitivity and specificity and provide unique real-time data analysis.

The team behind RapiDA has considerable experience of developing specialist ophthalmic instruments and techniques. Other innovative ophthalmic products are currently in the Mumac pipeline.

RapiDA in storage mode. Streamlined, compact and ergonomically designed, RapiDA has an extremely small footprint, making it ideal for busy clinics.

Clinical trials

RapiDA has successfully undergone extensive clinical trials funded by the National Institute of Health Research (NIHR).

View results

AMD: a major problem in people over 50

AMD is the biggest cause of sight loss in the UK and a major problem worldwide. In this country alone it affects over half a million people.

The disease leads to irreversible blindness when undiagnosed or, as is all too frequently the case, not diagnosed until it has reached an advanced stage, by which time it is too late.

RapiDA addresses this problem by allowing the earliest possible detection,when therapies can be effectively introduced top help prevent vision loss.